On November 18, 2025, Ice Miller participated in the Boston Life Sciences Showcase Investor Connect Series held at 10 Prospect Street in Union Square. The event convened founders, funders, and innovators for an afternoon of panels, presentations, and networking under the theme “Beyond Equity: Strategic Financing for Life Sciences.”

The highlight of the event was an investor panel moderated by Max Hunt of SVRN. Panelists Vinit Nijhawan, Managing Director at MassVentures, and Dr. Karen Reeves, Senior Vice President of Investments and Head of Clinical Strategy at Ligand Pharmaceuticals, explored innovative financing models, including royalty-based and revenue-linked approaches, reflecting on building a strong foundation early and communicating with clarity through storytelling. Ice Miller partner Mai Zymaris shared practical considerations for founders as they shape their intellectual property strategy.

The event also spotlighted emerging biotech companies Taja Health Technologies PBC, SilkMed, and IRIS Kinetics who are developing solutions across digital therapeutics, biomaterials, and molecular diagnostics.

Ice Miller is proud to support the life sciences community and provide strategic legal counsel across all stages of the innovation lifecycle.